Adenylate cyclase 4 suppresses malignant progression of lung adenocarcinoma through interaction with protein kinase C beta
Jieyang Wang, Chaojing Zheng, Wei Shen, Qianshun Chen, Yuyu Lin, Shuwei Huang, Lei Gao, Chen Huang · 2026
Read Adenylate cyclase 4 suppresses malignant progression of lung adenocarcinoma through interaction with protein kinase C beta by Jieyang Wang, Chaojing Zheng, Wei Shen, Qianshun Chen, Yuyu Lin, Shuwei Huang, Lei Gao, Chen Huang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13462150.txt.
Description
Jieyang Wang and co-authors report, in a 2026 study, that the signaling enzyme ADCY4 holds back lung adenocarcinoma, the most common form of lung cancer. The enzyme's job in this cancer was not known. Large gene data first flagged ADCY4 as reduced in tumors. The team measured it in tissue and cell lines and boosted its levels to watch effects on cancer cell behavior.
Low ADCY4 went with worse patient outlook and more advanced stage. Restoring the enzyme in cancer cells slowed growth, movement, and invasion in dish tests. The mechanism ran through a partner protein, PRKCB: ADCY4 binds it and raises its amount. Blocking the partner removed the benefit, showing the suppression depends on that link. Tumors grown in animals shrank when ADCY4 was restored, through the same partner route. The authors name ADCY4 a tumor suppressor in this lung cancer, and a possible marker and target.
Catalog record
| CREATOR | Jieyang Wang, Chaojing Zheng, Wei Shen, Qianshun Chen, Yuyu Lin, Shuwei Huang, Lei Gao, Chen Huang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |